Some of the views expressed in the following notes on newly approved products should be regarded as preliminary, as there may have been limited published data at the time of publication, and little experience in Australia of their safety or efficacy. However, the Editorial Executive Committee believes that comments made in good faith at an early stage may still be of value. Before new drugs are prescribed, the Committee believes it is important that more detailed information is obtained from the manufacturer's approved product information, a drug information centre or some other appropriate source.
Climen 28 (Schering)
packs containing 16 oestradiol valerate 2 mg tablets and 12 oestradiol valerate 2 mg/cyproterone acetate 1 mg tablets
